Emtricitabine And Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 65862-354

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 65862-354). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (200 mg/300 mg (30 Tablet Bottle))

This is a description of a medication called Emuricitabine and Tenofovir Disoproxil Fumarate tablets manufactured by Aurobindo Pharma USA, Inc. Each film-coated tablet contains 200 mg of Emuricitabine and 300 mg of Tenofovir Disoproxil Fumarate equivalent to 245 mg of tenofovir disoproxil. The usual dosage and administration is mentioned in the package insert. The medication should be stored at 20° to 25°C (68° to 77°F) and the tablets are permitted to have excursions of 15° to 30°C (59° to 86°F). A pharmacist should dispense the medication and keep the container tightly closed in its original container. The text also provides the NDC number, batch code, and company's address.*

FDA Label Image

Chemical Structure-1 (Emtriteno Str1)

FDA Label Image

Chemical Structure-2 (Emtriteno Str2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.